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doi:10.1016/j.ejvs.2008.02.010Abstract Objectives: To report results of subintimal angioplasty (SA) of superficial femoral
artery occlusions and to compare these results with percutaneous transluminal angioplasty
(PTA) of similar lesions.
Design: Prospective study.
Patients: In the period from June 2002 to August 2006, 73 SA procedures were performed in 71
patients and 75 PTA procedures were performed in 75 patients.
Methods: All cases treated with SA or PTA for superficial femoral artery occlusions were pro-
spectively registered and reviewed. Assessments of comorbidities, indication for procedure,
run-off, occlusion length, calcification of the artery and graft patency were recorded.
Results: The technical success rate of SA was 87.7% versus 81.3% for PTA. Primary patency
rates in the SA group at 1, 6, 12, 24 months were respectively 84.9  4.2, 71.2  5.1,
68.5  5.3 and 65.8  5.2%; in the PTA group e 81.3  4.4, 45.3  5.7, 42.7  5.6 and
38.7 5.5% respectively. At the same time-points primary assisted patency rates were in SA
group 84.9  4.2, 83.6  4.2, 71.2  5.2 and 68.5  5.3%; and in the PTA group 81.3  4.4,
62.5 5.5, 44 5.6 and 42.7 5.6%. Calcification was associated with SA failure. There were
no amputations in the follow up of either SA or PTA procedures.
Conclusion: Results from subintimal angioplasty of superficial femoral artery occlusions was
superior to the results of PTA.
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During the last two decades major changes have taken
place in the diagnostic and treatment techniques for
peripheral arterial disease (PAD). In the past, the main
treatments for PAD were thrombectomy, endarterectomyd by Elsevier Ltd. All rights reserved.
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by means of percutaneous transluminal angioplasty,4 subin-
timal angioplasty,5 laser angioplasty,6 thrombolysis,7 endo-
vascular thrombadsorbtion8 and endovascular stenting.9
Due to increasing longevity patients now present with
more coexistent illnesses, which often increase the risk of
surgery for PAD. Today many lesions can be treated by en-
dovascular methods, which are less invasive, can be per-
formed under local anaesthesia and are relatively cheap.
The aim of this study was to compare the results of subinti-
mal angioplasty (SA) and percutaneous transluminal angio-
plasty (PTA) for treatment of chronic occlusions of the
superficial femoral artery (SFA) and to identify factors asso-
ciated with the success or failure of subintimal angioplasty.Patients and Methods
One hundred and forty six patients with SFA occlusions were
treated from June 2002 to August 2006. Seventy three
subintimal angioplasties were performed in 71 patients (SA
group), while 75 percutaneous transluminal angioplasties
were performed in 75 patients (PTA group).
The SA group consisted of 51 men (71.8%) and 20 women
(28.2%), mean age 65.9 10.42 years (range from 36 to 84
years). Before SA treatment patients with intermittent
claudication underwent a 3 month period of medical treat-
ment, smoking cessation and regular walking exercises. All
patients, received 100e250 mg of aspirin daily, unless
contraindicated.
The indication for endovascular procedures (SA and PTA)
was chronic SFA occlusion. Exclusion criteria in both groups
(SA and PTA) were as follows: acute limb ischaemia;
significant haemodynamic stenosis in the aorto-iliac seg-
ment; stenosis of SFA; significant haemodynamic stenosis or
occlusion of the popliteal artery. For the SA procedure the
following criteria were used: all occlusion lengths, prefer-
ably 5 cm or longer occlusions; flush occlusion of the SFA.
The criteria for PTA were short occlusions (<5 cm length)
or non flush occlusion of the SFA. The lengths of SFA occlu-
sions were defined into type A, B, C, D, according to TASC
recommendations.10
SA was performed by a single interventional radiologist,
experienced in conventional percutaneous transluminal
angioplasty. Recanalizations were performed as described
by Bolia and Reekers.11,12 The ipsilateral antegrade ap-
proach was used in all cases. Subintimal entry was achieved
by pushing a 5 French straight angiography catheter into
the lesion. The occluded segment was then traversed
with a 0.0350 hydrophilic guide wire. The tip of guide wire
was looped during the passage and followed by a 5 French
straight catheter. After re-entry at the distal end of the le-
sion, the subintimal passage was dilated with either a 5 or
6 mm balloon angioplasty catheter, depending on the diam-
eter of the normal artery. If the new lumen was not stable
or was too narrow after the dilatation, Self-Expandable Pe-
ripheral Nitinol Stents were implanted. An open canal with
good antegrade flow at the end of the procedure was
defined as technical success. Good antegrade flow was de-
fined by the radiologist during angiography after the SA pro-
cedure. Procedures in which it was impossible to gain entry,
re-entry or obtain an acceptable flow through the canalwere regarded as technical failures. During the SA proce-
dure the patient was routinely given 5000 IU of intra-
arterial heparin and in cases of arteriospasm 0.5e1.0 mg
of intra-arterial glyceryl trinitrate was administered.
After the procedure, outpatient examinations were
performed at 1, 6, 12 and 24 months. Routine follow-up
consisted of colour-flow duplex scanning in the department
of radiology (Toshiba Applio model SSA-770 A, Fundamen-
tals 2B 730-595 E*J, Japan), ankle-brachial blood pressure
index (ABI) measurements at every follow-up visit and
evaluation of symptom recurrence. If the peak systolic
velocity (Vmax) increased more than 2-fold in either the SA
or PTA region, in comparison to early duplex scanning in this
SFA region after SA or PTA, the patient was referred for
angiography and, if necessary, the SFA stenosis was treated
by PTA. If SFA occlusion was observed, bypass surgery was
performed. If haemodynamically significant (>50%) stenosis
could not be confirmed by angiography, no further in-
tervention was performed and the patient continued under
routine follow-up. The primary and primary assisted pa-
tency were defined according to TASC recommendations.10
All PTA procedures were performed by standard technique.
The ipsilateral antegrade approach was used in most
procedures.
Statistical Methods
Post procedural data were collected into a computerized
registry and analyzed with SPSS 13 for Windows. Cumulative
SFA patency was estimated by Kaplan-Meier method. Com-
parisons of primary and primary assisted patency between
groups was performed using log rank (ManteleCox) test.
Statistical analysis of the data was performed using Fisher’s
exact test and Pearson’s c2 test for categorical data and Stu-
dent’s t-test for continuous variables, with statistical signif-
icance set at p< 0.05. Continuous variables are presented as
mean standard deviation (SD), patency rates as percenta-
ge standard error (SE). Patency rates and limb salvage
rates are based on the number of treated legs. When a de-
fined endpoint (occlusion) was not reached, the data were
censored at the last known follow-up.
Results
The indications for SA were disabling intermittent claudi-
cation (IC) in 38 cases (52.1%) and critical ischaemia (CI) as
defined by the TransAtlantic Inter-Society Consensus10 in 35
cases (47.9%). The indications for PTA were disabling IC in
29 cases (38.7%) and CI in 46 cases (61.3%). The demo-
graphic, clinical characteristics and risk factors of the SA
and PTA groups are compared in Table 1. The results from
angiography for both SA and PTA patients are shown in
Table 2.
The quality of the run-off was defined by the number of
patients with passable calf arteries: in the SA group good
run-off (2e3 arteries) was found in 53 limbs (72.6%) and
poor run-off (0e1 arteries) in 20 limbs (27.4%), while in the
PTA group in good run-off was found in 48 limbs (64%) and
poor run-off in 27 (36%) limbs. The difference between the
numbers of the occluded calf arteries in the SA and PTA
groups was not statistically significant.
Table 1 The demographic and clinical characteristics of the subintimal angioplasty and the percutaneous transluminal angio-
plasty groups
Variables SA group
(73 procedures)
% or SD PTA group
(75 procedures)
% or SD
Male/female 53/20 72.6/27.4 57/18 76/24
Age (years) 65.9 10.42 65.6 10.37
Age 75 years 14 19.2 10 13.3
Smoking history 53 72.6 53 70.7
Arterial hypertension 47 64.4 41 54.7
Diabetes mellitus 11 15.1 9 12
Ischaemic heart disease 39 53.4 40 53.3
Intermittent claudication 38 52.1 29 38.7
Critical ischaemia 35 47.9 46 61.3
Ankle-brachial pressure index 0.34 0.14 0.35 0.12
Previous bypass surgery 3 4.1 0 0
SD e standard deviation.
Superficial Femoral Artery Occlusions 103Sixty four of 73 SA procedures were considered techni-
cally successful. Technical failures occurred in 7 cases. In
addition, slow antegrade flow after SA was observed in 2
cases, which also were defined as technical failures. In
three cases Self-Expandable Peripheral Nitinol Stents for SA
procedure were used. Two procedures that were compli-
cated by distal embolization were treated successfully by
thrombectomy in one case and thrombolysis in the other.
Other complications included superficial haematomas in
two cases and arterial spasm in a further two other cases.
The initial outcomes of treatment by SA and PTA are
presented in Table 3.
Primary patency rates in SA group at 1, 6, 12, 24 months
were respectively 84.9 4.2, 71.2 5.1, 68.5 5.3 and
65.8 5.2% and in PTA group 81.3 4.4, 45.3 5.7,
42.7 5.6 and 38.7 5.5%, (Fig. 1). SA primary patency
was significantly higher than PTA primary patency (log
rank (ManteleCox) method e c2Z 18.959; p< 0.001).
Primary assisted patency rates calculated on intention
to treat basis in the SA group at 1, 6, 12, 24 months were
respectively 84.9 4.2, 83.6 4.2, 71.2 5.2 and
68.5 5.3% versus 81.3 4.4, 62.5 5.5, 44 5.6 and
42.7 5.6% for the PTA group (Fig. 2). SA primary assisted
patency was statistically significantly higher than for PTA
(log rank (ManteleCox) method e c2Z 70.889; p< 0.001).Table 2 The angiographic examination data of patients in the
minal angioplasty groups and their comparison
Factor SA group
(73 procedu
Mean length of occlusion (cm) (SD) 12 (5.57)*
Long occlusions (10 cm) 40*
Occlusion type A (cm) 2
Occlusion type B (cm) 37
Occlusion type C (cm) 22
Occlusion type D (cm) 12
Good run-off (Run e off 3/2 artery patent) 53
Bad run-off (Run e off 1/0 artery patent) 20
Calcification in SFA occlusion 15
*p< 0.05 between groups, SD e standard deviation, SFA e superficialThe median follow-up duration was 13 months (0e36) in
the SA group and 13.2 months (0e36) in the PTA group.
During follow-up no limb amputations were performed that
were attributed to either the SA or the PTA procedures.
Similarly no deaths were reported in either group. Conver-
sion to bypass surgery was performed in seven cases due to
the technical inability to perform subintimal angioplasty of
the SFA.
We observed that technical failures of SA occurred more
often when calcification of the SFA occlusion had been
noted (pZ 0.002). No factors were associated with the re-
sults of SA. Detailed analysis of the factors that were inves-
tigated influenced primary, primary assisted patency and
could predict technical failure of subintimal angioplasty
in the SA group patients is presented iare shown Table 4.
Discussion
Endovascular treatment of long SFA occlusions is contro-
versial because of unsatisfactory long-term patency and
complication rates. The promising results of subintimal
femoropopliteal recanalization published by London et al.,
with one year patency rates of 71%, indicated a new safe
approach to this problem that merits consideration.13 In
three recent prospective studies Florenes et al., Lazarissubintimal angioplasty and the control percutaneous translu-
res)
% PTA group
(75 procedures)
%
e 6.3 (3.56)* e
54.8 12* 16
2.7 17 22.7
50.7 51 68
30.2 6 8
16.4 1 1.3
72.6 48 64
27.4 27 36
20.5 18 24
femoral artery.
Table 3 The comparison of initial treatment outcomes in the subintimal angioplasty group and the control percutaneous
transluminal angioplasty group
Factor SA group
(73 procedures)
% PTA group (75 procedures) %
Technical success 64/73 87.7 61/75 81.3
Pulsation of popliteal artery 53/73 72.6 56/75 74.7
ABI mean after treatment (SD) 0.9 (0.2) e 0.87 (0.23) e
Increasing ABI up to 0.15 after treatment 66/73 90.4 63/75 84
Angiographical success with fast antegrade flow 64/73 87.7 61/75 81.3
Angiographical success with slow antegrade flow 2/73 2.7 7/75 9.3
Improvement of limb symptoms 66/73 90.4 62/75 82.6
Improvement of intermittent claudication (II st.) 36/38 94.7 27/29 93.1
Improvement of pain at rest (III st.) 11/14 78.6 24/30 80
Improvement when tissue loss is present (IV st.) 19/21 90.5 11/13 84.6
No improvement of limb symptoms 7 9.6 13 17.3
Complications 6 8.2 10 13.3
ABI e ankle-brachial index, SD e standard deviation.
104 A. Antusevas et al.et al. and McCarthy et al. presented 12 month overall pa-
tency rates for SA ranging from 53 to 70%.14e16 Our results
of a primary patency rate of 68.5% are similar. In contrast,
Laxdal et al. recently reported a 37% primary patency at
one year for femoropopliteal subintimal angioplasties.17
These results are poor compared to bypass surgery where
patency rates at one year are reported to be between
81% and 100%.18,19 PTA of moderate and long-segment SFA
occlusive disease is still controversial due to unsatisfactory
success and patency rates. The use of self-expanding nitinol
stents in these lesions seems to improve the results of the
procedure. In the SIROCCO I and II trials the primary
patency rates at 6 months were 76.5% and 92.3% among
patients with bare nitinol stents.20,21 Mid-term findings in
these studies showed a restenosis rate at 24 months of
only 21%.22 However, average lesion length in SIROCCO
was only 8.0 cm and only 2/3 of lesions were fully occluded.Figure 1 Kaplan-Meier probability curves of primary patency
after subintimal angioplasty and percutaneous transluminal
angioplasty.In the ABSOLUTE trial Schillinger et al. reported that the
6 month primary patency rate in stented patients was
76%.23 The recently published 2 year data from this trial
also favours the use of stents for long SFA lesions, with a sus-
tained benefit of primary stent implantation being
observed.24 It seems surprising that although lesion lengths
were similar in our study and the ABSOLUTE trial (average
lesion length was 13.2 cm and 12 cm, respectively), total
occlusions constituted only 1/3 of all lesions in the ABSO-
LUTE trial. Nevertheless SA may be better than conven-
tional PTA/stenting because at 24 months primary
patency rates in our study and the ABSOLUTE trial were
similar (65.8% and 54.3%).24
In our study the majority of re-occlusions occurred
within the first 6 months after SA. Therefore the earlyFigure 2 Kaplan-Meier probability curves of primary assisted
patency after subintimal angioplasty and percutaneous translu-
minal angioplasty.
Table 4 The detailed analysis of the factors predicting
technical failure, primary and primary assisted patency in
patients of subintimal angioplasty group
Factor Technical
failure
p value
Primary
patency
p value
Primary
assisted
patency
p value
Calcification in SFA occlusion 0.002 0.11 0.33
Long occlusions (10 cm) 1.00 0.12 0.10
Stage of chronic limb ischaemia 0.29 0.18 0.32
Arterial hypertension 0.48 0.30 0.10
Ischaemic heart disease 0.29 0.40 0.30
Bad run-off (Run e off 1/
0 artery patent)
0.25 0.41 0.95
Diabetes mellitus 0.62 0.46 0.31
Age 75 years 1.00 0.51 0.82
Smoking 0.69 0.59 0.74
Sex 0.42 0.62 0.51
Previous bypass surgery 1.00 0.81 0.14
Superficial Femoral Artery Occlusions 105post-procedural follow up is particularly important for
identifying factors associated with poor patency and for
the prevention of SFA re-occlusion.
The selection of patients suitable for SA has not yet been
defined clearly. Reekers et al., Aleksynas et al. found that
arterial calcification was predictive of technical fail-
ure.12,25 In our study calcification of SFA also influenced
technical success, but it did not affect primary assisted pa-
tency. Bolia et al., in addition, stated that the extensive
calcification, recent (3e6 months) occlusions and distal
atherosclerotic disease should not be treated with subinti-
mal recanalization.26
In our study, distal run-off was not related to re-
occlusion. London et al. found that run-off, smoking and
occlusion length were independent risk factors for reocclu-
sion.13 In our study, occlusion length and smoking were not
significantly associated with primary and primary assisted
patency. Recently, Lazaris et al. described a clinical study
of 51 infrainguinal SA procedures in 46 patients suffering
from CI. The 12 month patency in patients with more
than one run-off vessel was 81% compared to 25% in pa-
tients with only one run-off vessel. Regarding the length
of angioplasty, the hazard of re-occlusion was 1.02 for
every centimetre of occlusion (PZ 0.049).27 London et al.
reported similar results in patients with femoropopliteal
occlusion treated by SA.13 Comparable results have also
been reported by other investigators for percutaneous
transluminal infrainquinal angioplasty.28e30
The single-centre, non-randomized design of this pro-
spective controlled study warrants careful interpretation of
the results, and the small cohorts (SA nZ 73, PTA nZ 75)
might have introduced bias. Such bias can only be removed
by a randomized trial comparing SA and PTA of SFA occlu-
sions. Another limitation of our study was that the types
of occlusion, particularly for types A, C, D differed too be-
tween the SA and PTA groups. Subintimal angioplasty ap-
peared superior to conventional PTA of SFA occlusions.
Calcification of SFA had a significant predictive value for
technical failure of SA procedure. Subintimal angioplastydoes not preclude later successful vascular surgery and,
in our Department, SA now is the first choice procedure
for patients with PAD, especially those with severe
comorbidities.
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